Case Reports
Malabsorption syndrome with IgG(lambda) M component: response to chemotherapy
- PMID: 817794
- PMCID: PMC1957076
Item in Clipboard
Case Reports
Malabsorption syndrome with IgG(lambda) M component: response to chemotherapy
Can Med Assoc J.
.
Abstract
A patient with malabsorption syndrome and steatorrhea was found to have IgG (lambda) M component in the blood and some extracellular deposition of IgG in the intestinal wall. There was no evidence of multiple myeloma. He responded favourably to intermittent courses of melphalan and prednisone.
Similar articles
-
[A case of IgG lambda myeloma associated with hyperviscosity syndrome. A speculative mechanism of hyperviscosity syndrome with relative low serum viscosity (author's transl)].Rinsho Ketsueki. 1979 Jun;20(6):658-66. Rinsho Ketsueki. 1979. PMID: 112269 Japanese. No abstract available.
-
[Hyperviscosity syndrome as the initial manifestation of IgG myeloma].Rev Clin Esp. 1982 Aug 15-31;166(3-4):181-2. Rev Clin Esp. 1982. PMID: 6815728 Spanish. No abstract available.
-
[Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].Rinsho Ketsueki. 1989 Mar;30(3):361-5. Rinsho Ketsueki. 1989. PMID: 2504973 Japanese.
-
[The value of disaccharide determination, associated with histological studies of the small intestine, in various stages if celiac disease and other malabsorption disorders].Orv Hetil. 1988 Oct 2;129(40):2127-31. Orv Hetil. 1988. PMID: 3050777 Review. Hungarian. No abstract available.
-
Crystalglobulin-induced vasculopathy accompanying ischemic intestinal lesions of a patient with myeloma.Pathol Int. 1996 Feb;46(2):165-70. doi: 10.1111/j.1440-1827.1996.tb03594.x. Pathol Int. 1996. PMID: 10846566 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources